• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逆转录聚合酶链反应(RT-PCR)检测非小细胞肺癌中ALK的性能与荧光原位杂交(FISH)及免疫组织化学的比较

Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer.

作者信息

Hout David R, Schweitzer Brock L, Lawrence Kasey, Morris Stephan W, Tucker Tracy, Mazzola Rosetta, Skelton Rachel, McMahon Frank, Handshoe John, Lesperance Mary, Karsan Aly, Saltman David L

机构信息

Insight Genetics, Inc., Suite 510, 2 International Plaza, Nashville, TN 37217, USA.

Department of Pathology and Laboratory Medicine, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada.

出版信息

Cancers (Basel). 2017 Aug 1;9(8):99. doi: 10.3390/cancers9080099.

DOI:10.3390/cancers9080099
PMID:28763012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5575602/
Abstract

Patients with lung cancers harboring an activating anaplastic lymphoma kinase () rearrangement respond favorably to ALK inhibitor therapy. Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) are validated and widely used screening tests for rearrangements but both methods have limitations. The ALK RGQ RT-PCR Kit (RT-PCR) is a single tube quantitative real-time PCR assay for high throughput and automated interpretation of expression. In this study, we performed a direct comparison of formalin-fixed paraffin-embedded (FFPE) lung cancer specimens using all three ALK detection methods. The RT-PCR test (diagnostic cut-off Δ of ≤8) was shown to be highly sensitive (100%) when compared to FISH and IHC. Sequencing of RNA detected full-length transcripts or and fusion variants in discordant cases in which expression was detected by the ALK RT-PCR test but negative by FISH and IHC. The overall specificity of the RT-PCR test for the detection of ALK in cases without full-length expression was 94% in comparison to FISH and sequencing. These data support the ALK RT-PCR test as a highly efficient and reliable diagnostic screening approach to identify patients with non-small cell lung cancer whose tumors are driven by oncogenic ALK.

摘要

携带激活型间变性淋巴瘤激酶(ALK)重排的肺癌患者对ALK抑制剂治疗反应良好。荧光原位杂交(FISH)和免疫组织化学(IHC)是经过验证且广泛应用于ALK重排的筛查检测方法,但这两种方法都有局限性。ALK RGQ逆转录聚合酶链反应试剂盒(RT-PCR)是一种单管定量实时PCR检测方法,用于高通量自动解读ALK表达。在本研究中,我们使用所有三种ALK检测方法对福尔马林固定石蜡包埋(FFPE)肺癌标本进行了直接比较。与FISH和IHC相比,RT-PCR检测(诊断临界值Δ≤8)显示出高度敏感性(100%)。在ALK RT-PCR检测显示ALK表达但FISH和IHC检测为阴性的不一致病例中,RNA测序检测到全长ALK转录本或ALK和EML4融合变体。与FISH和测序相比,RT-PCR检测在无全长ALK表达病例中检测ALK的总体特异性为94%。这些数据支持ALK RT-PCR检测作为一种高效可靠的诊断筛查方法,用于识别肿瘤由致癌性ALK驱动的非小细胞肺癌患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4a/5575602/27e280e8aa9d/cancers-09-00099-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4a/5575602/66bab0ef8973/cancers-09-00099-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4a/5575602/27e280e8aa9d/cancers-09-00099-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4a/5575602/66bab0ef8973/cancers-09-00099-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb4a/5575602/27e280e8aa9d/cancers-09-00099-g002.jpg

相似文献

1
Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer.逆转录聚合酶链反应(RT-PCR)检测非小细胞肺癌中ALK的性能与荧光原位杂交(FISH)及免疫组织化学的比较
Cancers (Basel). 2017 Aug 1;9(8):99. doi: 10.3390/cancers9080099.
2
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays.一种基于快速简便的逆转录聚合酶链反应(RT-PCR)的ALK检测新算法在大量肺腺癌中的验证:与荧光原位杂交(FISH)、免疫组织化学和下一代测序检测的比较
Lung Cancer. 2016 Sep;99:11-6. doi: 10.1016/j.lungcan.2016.06.005. Epub 2016 Jun 14.
3
A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimens.一种基于TaqMan的灵敏且高通量的逆转录定量聚合酶链反应检测方法,能够有效地区分肺癌福尔马林固定石蜡包埋(FFPE)标本中的ALK重排与过表达。
Lung Cancer. 2016 Apr;94:114-20. doi: 10.1016/j.lungcan.2016.02.004. Epub 2016 Feb 10.
4
Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.采用新型、灵敏、定量逆转录聚合酶链反应检测试剂盒检测福尔马林固定石蜡包埋肺癌标本中 ALK 的重排和转录上调。
J Thorac Oncol. 2014 Mar;9(3):307-15. doi: 10.1097/JTO.0000000000000068.
5
Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma.新型全自动免疫化学检测在原发性肺腺癌中检测 ALK 重排的诊断价值。
Ann Oncol. 2013 Oct;24(10):2589-2593. doi: 10.1093/annonc/mdt295. Epub 2013 Jul 31.
6
Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.反转录-聚合酶链反应、免疫组织化学和荧光原位杂交方法检测棘皮动物微管相关蛋白样 4-间变性淋巴瘤激酶融合阳性非小细胞肺癌的比较:对最佳临床检测的影响。
Arch Pathol Lab Med. 2012 Jul;136(7):796-803. doi: 10.5858/arpa.2011-0321-OA.
7
Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements.免疫组织化学(IHC)、荧光原位杂交(FISH)和 RT-PCR 检测 EML4-ALK 重排的一致性。
Transl Lung Cancer Res. 2014 Apr;3(2):70-4. doi: 10.3978/j.issn.2218-6751.2014.02.02.
8
Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-small cell lung cancer: a comparison of Ventana immunohistochemistry and fluorescence in situ hybridization.晚期非小细胞肺癌患者恶性胸腔积液细胞块中ALK重排的检测:Ventana免疫组织化学与荧光原位杂交的比较
Cancer Cytopathol. 2015 Feb;123(2):117-22. doi: 10.1002/cncy.21510. Epub 2014 Dec 19.
9
[A standardized protocol for detection of ALK protein expression and gene fusion in lung adenocarcinoma cytologic specimens].[一种用于检测肺腺癌细胞学标本中ALK蛋白表达及基因融合的标准化方案]
Zhonghua Zhong Liu Za Zhi. 2015 Oct;37(10):742-8.
10
Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.免疫组织化学检测肺腺癌中的 ALK 重排及新型 EML4-ALK 变异体的鉴定。
J Thorac Oncol. 2013 Jul;8(7):883-91. doi: 10.1097/JTO.0b013e3182904e22.

引用本文的文献

1
Novel Targets, Novel Treatments: The Changing Landscape of Non-Small Cell Lung Cancer.新型靶点与新型疗法:非小细胞肺癌不断变化的格局
Cancers (Basel). 2023 May 21;15(10):2855. doi: 10.3390/cancers15102855.
2
Role of Myeloperoxidase in ROS Generation and Inflammation Response on Prostate Epithelial Cells.髓过氧化物酶在前列腺上皮细胞活性氧生成及炎症反应中的作用
Inflammation. 2023 Oct;46(5):1859-1870. doi: 10.1007/s10753-023-01846-x. Epub 2023 Jun 15.
3
Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer.治疗非小细胞肺癌中罕见 ALK 融合的新进展。

本文引用的文献

1
Differential protein stability and clinical responses of EML4-ALK fusion variants to various ALK inhibitors in advanced ALK-rearranged non-small cell lung cancer.晚期 EML4-ALK 融合变异型非小细胞肺癌中不同蛋白稳定性与各种 ALK 抑制剂的临床反应。
Ann Oncol. 2017 Apr 1;28(4):791-797. doi: 10.1093/annonc/mdw693.
2
Anaplastic lymphoma kinase L1198F and G1201E mutations identified in anaplastic thyroid cancer patients are not ligand-independent.在间变性甲状腺癌患者中鉴定出的间变性淋巴瘤激酶L1198F和G1201E突变并非不依赖配体。
Oncotarget. 2017 Feb 14;8(7):11566-11578. doi: 10.18632/oncotarget.14141.
3
ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.
Curr Oncol. 2022 Oct 16;29(10):7816-7831. doi: 10.3390/curroncol29100618.
4
ALK inhibitors in ALK-rearranged non-small cell lung cancer with and without brain metastases: systematic review and network meta-analysis.ALK 抑制剂治疗伴有和不伴有脑转移的 ALK 重排非小细胞肺癌的系统评价和网络荟萃分析。
BMJ Open. 2022 Sep 19;12(9):e060782. doi: 10.1136/bmjopen-2022-060782.
5
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.1p/19q 缺失检测在少突胶质细胞瘤诊断中的准确性:一项基于 Cochrane 系统评价的综合荟萃分析。
Neuropathol Appl Neurobiol. 2022 Jun;48(4):e12790. doi: 10.1111/nan.12790. Epub 2022 Mar 3.
6
Pathological cytomorphologic features and the percentage of ALK FISH-positive cells predict pulmonary adenocarcinoma prognosis: a prospective cohort study.病理细胞形态特征和 ALK FISH 阳性细胞的百分比可预测肺腺癌的预后:一项前瞻性队列研究。
World J Surg Oncol. 2021 Sep 16;19(1):278. doi: 10.1186/s12957-021-02386-0.
7
The Prevalence of the EML4-ALK Fusion Gene in Cytology Specimens from Patients with Lung Adenocarcinoma.肺腺癌细胞学标本中 EML4-ALK 融合基因的流行率。
Pulm Med. 2020 Dec 23;2020:3578748. doi: 10.1155/2020/3578748. eCollection 2020.
8
Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK Rearrangements and Predicting the Efficacy of First-Line Crizotinib in Patients with Advanced Non-Small Cell Lung Cancer.新一代测序与Ventana免疫组化在检测晚期非小细胞肺癌患者ALK重排及预测一线克唑替尼疗效中的比较
Onco Targets Ther. 2020 Jul 22;13:7101-7109. doi: 10.2147/OTT.S265974. eCollection 2020.
9
Chinese perspectives on clinical efficacy and safety of alectinib in patients with -positive advanced non-small cell lung cancer.中国对于阿来替尼在ALK阳性晚期非小细胞肺癌患者中的临床疗效和安全性的观点。
Onco Targets Ther. 2019 Aug 14;12:6481-6495. doi: 10.2147/OTT.S185115. eCollection 2019.
10
The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis.ALK融合蛋白在肿瘤发生中的转录作用
Cancers (Basel). 2019 Jul 30;11(8):1074. doi: 10.3390/cancers11081074.
肺腺癌中ALK荧光原位杂交(FISH)模式及通过下一代测序检测ALK融合
Oncotarget. 2016 Dec 13;7(50):82943-82952. doi: 10.18632/oncotarget.12705.
4
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays.一种基于快速简便的逆转录聚合酶链反应(RT-PCR)的ALK检测新算法在大量肺腺癌中的验证:与荧光原位杂交(FISH)、免疫组织化学和下一代测序检测的比较
Lung Cancer. 2016 Sep;99:11-6. doi: 10.1016/j.lungcan.2016.06.005. Epub 2016 Jun 14.
5
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations.非小细胞肺癌中ALK基因拷贝数增加:预后影响及临床病理相关性
Respir Res. 2016 Aug 25;17(1):105. doi: 10.1186/s12931-016-0422-8.
6
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer.非小细胞肺癌中ALK重排分析结果不一致。
BMC Cancer. 2016 Aug 5;16:603. doi: 10.1186/s12885-016-2646-x.
7
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.综合基因组分析鉴定出一组荧光原位杂交未检测到的对克唑替尼敏感的ALK重排非小细胞肺癌。
Oncologist. 2016 Jun;21(6):762-70. doi: 10.1634/theoncologist.2015-0497. Epub 2016 May 31.
8
Successful treatment of hepatic oligometastases with stereotactic ablative radiotherapy and radiofrequency ablation in an anaplastic lymphoma kinase fusion-positive lung cancer patient.立体定向消融放疗联合射频消融成功治疗1例间变性淋巴瘤激酶融合阳性肺癌患者的肝寡转移灶
J Med Radiat Sci. 2016 Mar;63(1):67-70. doi: 10.1002/jmrs.144. Epub 2015 Oct 3.
9
Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas.非小细胞肺癌中 Ventana ALK(D5F3)伴随诊断检测的概况。
Expert Rev Mol Diagn. 2016 Jun;16(6):707-13. doi: 10.1586/14737159.2016.1172963. Epub 2016 Apr 15.
10
A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimens.一种基于TaqMan的灵敏且高通量的逆转录定量聚合酶链反应检测方法,能够有效地区分肺癌福尔马林固定石蜡包埋(FFPE)标本中的ALK重排与过表达。
Lung Cancer. 2016 Apr;94:114-20. doi: 10.1016/j.lungcan.2016.02.004. Epub 2016 Feb 10.